1,442
Views
7
CrossRef citations to date
0
Altmetric
Letters to the Editor

A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma

, , , , , , & show all
Pages 589-590 | Received 28 Jul 2010, Accepted 12 Aug 2010, Published online: 12 Jan 2011

Figures & data

Figure 1. Positron Emission Tomography (PET) images revealing fluorodeoxyglucose (FDG) avid left submandibular lymphadenopathy at diagnosis (figure 1a) that showed no response following 3 cycles of SMILE chemotherapy (figure 1b), but resolved completely with 2 cycles of B-GIFOX (figure 1c).

Figure 1. Positron Emission Tomography (PET) images revealing fluorodeoxyglucose (FDG) avid left submandibular lymphadenopathy at diagnosis (figure 1a) that showed no response following 3 cycles of SMILE chemotherapy (figure 1b), but resolved completely with 2 cycles of B-GIFOX (figure 1c).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.